secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2024-09-24T23:59:59+00:00
Accession:  0001520138-24-000310
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie prices $3M public offering of 1.96M units at $1.53/share with warrants
-----------------------------------------------------------------------------

- Gross proceeds ~$3M from 1,960,800 units at $1.53 each; each unit includes share or pre-funded warrant plus 5-year warrant exercisable at $1.53.
- Offering expected to close September 25, 2024; ThinkEquity acting as sole placement agent.
- Net proceeds to be used for working capital and general corporate purposes.
- BioVie is a clinical-stage company focused on liver disease and neurodegenerative disorders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000310/0001520138-24-000310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013824000310/bivi-20240923_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-24-000310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer